The path to superior* outcomes for your low-risk symptomatic severe AS patients starts with timely intervention... and your guidance1

The ACC/AHA released key updates in their recent 2020 Guideline for Valvular Heart Disease (VHD), including guidance for the treatment of symptomatic severe aortic stenosis (SAS) and transcatheter valve repair/implantation (TAVR/I). The guideline recommends guiding all sSAS patients to a multidisciplinary Heart Team.

Updated AHA/ACC Guideline recommends TAVR for more patients based on expanded indications

A proven and less invasive option isn’t just for the highest-risk patients anymore.2 Edwards SAPIEN 3 TAVR— the only TAVR proven superior* to surgery is now open for low-risk patients.

Read the guideline

Test your knowledge with a quick assessment about TAVR and symptomatic severe aortic stenosis

Go to the quiz

You have the power to give your low-risk patients a chance at superior* outcomes by guiding them to a Heart Team for a TAVR evaluation

Click each member of the Heart Team for details on the role and perspective of each specialist in evaluating patients and performing TAVR procedures.

Cardiothoracic Surgeon

With the partnership of the interventional cardiologist, the cardiothoracic surgeon will determine which patients may be considered candidates for TAVR. For certain TAVR procedures, the surgeon will take the lead on the TAVR procedure.

Valve Clinic Coordinator

The Valve Clinic Coordinator (VCC) facilitates each step in the TAVR process and supports patients during this challenging time. The coordinator serves as the primary point of contact to help patients and caregivers navigate the care process from the time of referral through follow-up care, and ensures streamlined communication among a specialized Heart Team, the patient and the referring physician(s).


The anesthesiologist will work to provide sedation during the procedure as well as provide post‑procedure care.

Referring Cardiologist

The Cardiologist will most likely be the first specialist you are referred to after a visit with the primary care physician. The cardiologist will confirm the diagnosis of severe aortic stenosis (SAS). If aortic valve replacement is required, you may be referred to a specialized Heart Team.

Imaging Specialist

Imaging specialist conducts procedures that aim to provide the most accurate view of heart valves from diagnosis to post-procedure.

Interventional Cardiologist

Interventional cardiologist specializes in catheter-based heart procedures and will work with the cardiothoracic surgeon to determine the right candidates for TAVR.

* The PARTNER 3 trial, SAPIEN 3 TAVR proven superior to surgery on the primary endpoint all-cause death, all stroke, and rehospitalization (excludes multiplicity adjustment) and multiple pre-specified secondary endpoints. Rehospitalization is defined as valve-related, procedure-related and including heart failure.

With so much at stake, there is no room for compromise. Edwards SAPIEN 3 TAVR helps you:

Deliver outcomes you demand


death or disabling stroke at 1 year in low risk patients1

Perfect the pathway through efficient procedures


of patients discharged the next day3

Control for the future to continue to meet the emerging needs of new patient populations


successful post-TAVR coronary access (68/68 patients)4

*Study includes both SAPIEN XT and SAPIEN 3 valves.

References:   1. Mack MJ, Leon MB, Thourani VH. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019;380(18):1695-1705. 2. 2020 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease. / ACC 2020;63(22);e57-185_ 3. Wood, D.A.; Lauck, S.B.; Cairns, J.A. et al. The Vancouver 3M (multidisciplinary, multimodality, but minimalist) clinical pathway facilitates safe next-day discharge home at low-, medium-, and high-volume transfemoral transcatheter aortic valve replacement centers: The 3M TAVI Study. J Am Coll Cardiol Intv. 2019. 4.  Tarantini G, Fovino LN, Le Prince P, et al. Coronary access and percutaneous coronary intervention up to 3 years after transcatheter aortic valve implantation with a balloon-expandable valve. Circ Cardiovasc Interv. 2020;13(7):e008972.